DDIT3 and diffuse large B-cell lymphoma: The main purpose of this prospective head-to-head comparison was to determine whether iFLT-PET/CT is a superior predictor of PFS compared with iFDG-PET/CT in patients with DLBCL treated with 6 cycles of R-CHOP or R-EPOCH given every 21 days.